Foresite Capital Opportunity Management V’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$5.56M Hold
959,275
16.71% 2
2022
Q2
$5.31M Buy
959,275
+490,455
+105% +$2.71M 13.37% 2
2022
Q1
$5.41M Hold
468,820
7.57% 3
2021
Q4
$5.95M Buy
+468,820
New +$5.95M 3.99% 5